Compare Abeona Therapeutics Inc (ABEO) vs Global X Autonomous & Electric Vehicles (DRIV) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Abeona Therapeutics Inc vs Global X Autonomous & Electric Vehicles — how do they compare? Abeona Therapeutics Inc trades at $6.73 (market cap $373.32M), while Global X Autonomous & Electric Vehicles trades at $35.85. The key difference: Abeona Therapeutics Inc is trading nearer its 52-week high, Global X Autonomous & Electric Vehicles nearer its low. Which is the better fit depends on your goals.
| ABEO | DRIV | |
|---|---|---|
Market Cap | $373.32M | — |
Sector | Health | Sector/Thematic |
52-Week High | $7.23 | $42.53 |
52-Week Low | $4.17 | $23.67 |
Enterprise Value | $228.22M | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ABEO trades at $6.31, down 1.41% today, with a bullish technical outlook supported by moving averages. The company reported Q1 2026 results with revenue growth and beat EPS expectations, while maintaining strong profitability margins. Recent news highlights expansion of treatment centers and new cell therapy licensing.
Outlook remains positive with analyst consensus favoring Buy ratings (66.67%), though high RSI indicates potential near-term overbought conditions. Key risks include negative operating cash flow and reliance on new treatment adoption. Upside depends on continued commercial execution and pipeline advancements.
DRIV trades at $37.63, up 2.42% today, but technical signals are bearish with moving averages indicating selling pressure. The stock faces industry headwinds from shifting consumer demand and geopolitical tensions affecting fuel prices. Recent news highlights competitive threats from Chinese EV makers and regulatory uncertainties in the U.S. market, while a dividend of $0.07 is scheduled for July 2026.
Outlook remains cautious due to bearish technicals and sector volatility. Investment opportunities lie in exposure to autonomous driving and EV growth, but risks include intense competition, regulatory changes, and macroeconomic pressures. Wall Street sentiment is mixed, reflecting the ETF's diversified tech and auto holdings amid evolving market dynamics.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Abeona Therapeutics Inc
Abeona Therapeutics develops gene and cell therapies for rare diseases. Its lead product, ZEVASKYN, is an FDA-approved therapy for recessive dystrophic epidermolysis bullosa (RDEB), a severe and life-threatening genetic skin disorder.
Read more on ABEO →About Global X Autonomous & Electric Vehicles
DRIV invests in companies involved in autonomous driving and electric vehicle production. It tracks the Solactive Autonomous & Electric Vehicles Index, focusing on software and hardware leaders like Tesla, NVIDIA, and Microsoft.
Read more on DRIV →
